Align Technology Earnings Call Transcripts
Fiscal Year 2026
-
Growth is driven by international expansion, product innovation, and digital adoption, with double-digit gains in key markets and DSOs. Margin improvements stem from product mix and operational efficiencies, while capital allocation focuses on buybacks and reinvestment.
-
International growth remains strong, with new product rollouts and cost actions supporting margin improvement. Financing programs and practice management integrations are driving higher patient conversion, while lab partnerships are expanding reach to general dentists and creating incremental revenue opportunities.
-
The event highlighted advances in digital orthodontics, including AI-driven treatment planning, 3D printing, and remote monitoring, which reduce patient visits and improve outcomes. Flexible business models and financing options are driving adoption among practitioners and patients.
-
The conference highlighted ongoing innovation in product solutions, direct fabrication, and financing initiatives, with pilots transitioning to broader rollout. International markets and DSOs are driving double-digit growth, while margin expansion and prudent guidance reflect a focus on operational efficiency.
-
Q1 2026 revenue grew 6.2% year-over-year to $1.04B, led by record clear aligner volumes and strong international growth. Guidance for FY 2026 is reaffirmed, with continued margin expansion and disciplined capital allocation amid macro uncertainty.
-
Revenue and volume growth were broad-based, with strong results in both teen and adult segments and double-digit DSO expansion. Growth is driven by active conversion, new products, and emerging markets, while ASP is impacted by mix. The company maintains a strong balance sheet and expects stable, mid-single-digit growth in 2026.
-
Market stability in North America and strong double-digit growth in Europe and APAC are supported by product innovation, especially zero refinement cases and digital workflow integration. Margin expansion is driven by cost reductions and manufacturing upgrades, while a robust supply chain ensures resilience amid geopolitical challenges.
Fiscal Year 2025
-
Q4 and full year 2025 saw record revenues and strong clear aligner volume growth, driven by international markets and DSOs, with non-GAAP margins exceeding expectations. 2026 guidance projects 3%-4% revenue growth, mid-single digit aligner volume growth, and continued margin improvement, while monitoring macro and regulatory risks.
-
The event highlighted new aligner products, including a no-refinement option, and the upcoming launch of direct fabrication technology. Strong margin improvements are expected from product mix and cost actions, with regional growth led by DSOs and international expansion.
-
U.S. and international markets show stable or accelerating growth, with DSOs and new products driving adoption. China’s VBP policy is expected to narrow price gaps and boost clear aligner volume, while portfolio innovation focuses on zero-refinement options and direct fabrication, supporting future expansion.
-
Global leadership in clear aligners is reinforced by advanced technology, regional manufacturing, and a flexible product portfolio. Growth is driven by DSO expansion, targeted marketing, and new product rollouts, while operational efficiencies and margin improvements are prioritized for 2026.
-
Year-over-year growth was broad-based across most regions, driven by new products, increased doctor engagement, and active conversion strategies. Product innovation and flexible scanner adoption models support volume growth, while premium pricing and a focus on converting traditional cases remain central. DSOs and local marketing are key to future expansion.
-
Q3 2025 saw 1.8% year-over-year revenue growth, led by strong international clear aligner demand and double-digit DSO growth, while North America retail remained mixed. Non-GAAP operating margin rose to 23.9%, and new digital workflow innovations were launched. Q4 and 2025 guidance project continued margin improvement and mid-single digit aligner volume growth.
-
New flexible pricing options and financing features are being introduced to boost adoption and competitiveness, while regional performance remains mixed due to economic factors. Significant R&D investment in direct fab 3D printing and ongoing IP protection efforts are expected to drive future growth and margin expansion.
-
Revenue growth for 2024 is revised down due to lower volumes in Western markets, but recovery is expected in Q4 from seasonal trends and new products. Innovation in direct fabrication and operational streamlining support margin goals, while the teen market and restorative cases offer significant growth potential.
-
Q2 saw less sequential growth than expected, with interest rates impacting patient conversion and financing. Q4 is expected to improve due to seasonality, new products, and cost initiatives. Emerging markets and DSOs are driving double-digit growth, while product mix shifts may lower ASPs but support margins.
-
Q2 2025 revenues were $1.012B, up sequentially but down year-over-year, with strong Systems and Services growth offset by softer Clear Aligner demand in North America and Europe. The company announced restructuring actions and expects Q3 revenues to decline sequentially due to seasonality and one-time charges.
-
The event highlighted a new phase of innovation, including AI-driven software and direct printing, and detailed strong growth strategies in EMEA through tailored market approaches and a successful peer-to-peer mentorship program. Recent product launches and next-gen software are driving efficiency and adoption.
-
The conference highlighted strong double-digit growth in APAC and EMEA, stable North American performance, and the impact of new products like IPE and MAOB in expanding market segments. Operational efficiencies and automation are supporting margin expansion, while direct fabrication is expected to be accretive by 2027.
-
Strong Q1 results were driven by broad-based growth and innovation in digital workflows and 3D printing. The updated long-range plan targets accelerated growth post-2028, supported by new products, emerging market expansion, and a doctor-focused strategy.
-
The event outlined a strategy to make digital tooth movement the global standard, leveraging AI, 3D printing, and a broadening product portfolio to drive growth across ortho, GP, and DSO channels. Financial guidance targets 3.5%-5.5% revenue growth in 2025 and 5%-15% annually through 2028, with ongoing investments in innovation and operational efficiency.
-
Q1 2025 saw stable revenues and margins, with Clear Aligner volumes up year-over-year, especially in teens and adults across all regions. Guidance calls for sequential growth in Q2 and mid-single digit Clear Aligner volume growth for 2025, despite FX and tariff headwinds.
Fiscal Year 2024
-
Q4 and full-year 2024 saw revenue and volume growth, with strong performance in international markets and robust scanner sales. Guidance for 2025 anticipates low single-digit revenue growth, mid-single-digit Clear Aligner volume growth, and margin accretion despite FX headwinds.
-
Recurring revenue from scanner leasing and services is rising, supported by expanded financing and a growing product portfolio. Strong adoption of new digital tools and manufacturing innovation are driving growth, especially in underpenetrated markets like China and the teen segment.
-
Market stability varies by region, with growth in teens and new products driving performance. Operational flexibility in manufacturing and a focus on doctor-led treatment position the business well against competitors and potential trade policy changes. Sequential improvement is expected in Q4, with mid-single digit growth as a baseline for 2025.
-
Strong growth in Asia and emerging markets offset weaker U.S. and Europe, with new products like Lumina and IPE driving future expansion. Margin management and organizational simplification support profitability, while capital allocation remains focused on growth and shareholder returns.
-
Management remains focused on long-term growth, balancing investments with margin discipline amid challenging market conditions. Recovery is seen in several international markets, with technology innovations like Direct Fab and iTero Lumina set to drive future growth and efficiency.
-
Q3 2024 saw 1.8% revenue growth year-over-year, driven by strong international performance and systems and services, but offset by U.S. market weakness and seasonality. Restructuring actions and investments in technology are expected to support margin accretion in 2025.
-
The global orthodontics market is stable, with strong growth opportunities in the teen segment and new product innovations like the Invisalign Palatal Expander and iTero Lumina scanner. ASPs are expected to remain flat to slightly down, while flexible financial strategies and expanded doctor programs support adoption and margin growth.
-
Q2 2024 saw revenue growth of 2.6% year-over-year, driven by higher clear aligner volumes and strong Systems and Services performance, though ASPs declined due to FX and product mix. FY 2024 revenue growth is expected at 4%-6%, with non-GAAP operating margin above 2023.
-
Strong Q1 results and new product launches led to raised revenue guidance, with both clear aligner and systems/services segments contributing. Lumina scanner and Invisalign Palatal Expander are driving innovation, while margin and cash flow improvements support ongoing investments and partnerships.
-
The event highlighted major innovations in dental aligners, including the launch of the iTero Lumina scanner and direct 3D printing of aligners, driving efficiency and expanding treatment capabilities. Strong Q1 results and raised full-year guidance reflect stable markets and successful new product adoption.